Cargando…
Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India
BACKGROUND: Parenteral artesunate is the treatment of choice for severe malaria. It is safe, efficacious and well tolerated anti-malarial. However, delayed haemolysis has been reported in travellers, non-immune individuals and in African children. METHODS: A prospective, observational study was carr...
Autores principales: | Savargaonkar, Deepali, Das, Manoj Kumar, Verma, Amar, Mitra, Jeevan K., Yadav, C. P., Srivastava, Bina, Anvikar, Anupkumar R., Valecha, Neena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977313/ https://www.ncbi.nlm.nih.gov/pubmed/31969146 http://dx.doi.org/10.1186/s12936-020-3120-4 |
Ejemplares similares
-
Genotyping of Plasmodium vivax by minisatellite marker and its application in differentiating relapse and new infection
por: Das, Ram, et al.
Publicado: (2016) -
A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India
por: Srivastava, Prakriti, et al.
Publicado: (2013) -
Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India
por: Anvikar, Anupkumar R, et al.
Publicado: (2012) -
Treatment for Severe Malaria: Post-Artesunate Delayed Haemolysis and Neutropenia
por: Martino, Mariangela, et al.
Publicado: (2022) -
Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India
por: Mishra, Neelima, et al.
Publicado: (2014)